Home > Financial Ratios > VAISHALI PHARMA

VAISHALI PHARMA
EV/Core EBITDA

    Back to All Ratios
COMMUNITY POLL
for VAISHALI PHARMA
Please provide your vote to see the results

VAISHALI PHARMA Last 5 Year EV/Core EBITDA History

[Standalone]

Mar2023Mar2022Mar2021Mar2020Mar2019
   EV/Core EBITDA(x) 14.3510.2811.5519.0311.18

What is the latest EV/Core EBITDA ratio of VAISHALI PHARMA ?

The latest EV/Core EBITDA ratio of VAISHALI PHARMA is 14.35 based on Mar2023 Standalone results.
Year EV/Core EBITDA
Mar202314.35
Mar202210.28
Mar202111.55
Mar202019.03
Mar201911.18

How is EV/Core EBITDA of VAISHALI PHARMA Trending?

Years EV/Core EBITDA % Change
Mar2023 14.35
39.59
Mar2022 10.28
-11.00
Mar2021 11.55
-39.31
Mar2020 19.03
70.21
Mar2019 11.18 -

Other Financial Ratios of VAISHALI PHARMA


Compare EV/Core EBITDA ratio of peers of VAISHALI PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
VAISHALI PHARMA ₹178.3 Cr -4.4% -0.5% 13.8% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹369,570.0 Cr 0.3% 0.1% 65.8% Stock Analytics
CIPLA ₹119,627.0 Cr 4.3% 9.4% 57.8% Stock Analytics
ZYDUS LIFESCIENCES ₹108,316.0 Cr 6.7% 12.2% 114.6% Stock Analytics
DIVIS LABORATORIES ₹107,804.0 Cr 3.3% 8.7% 27.3% Stock Analytics
DR REDDYS LABORATORIES ₹97,966.5 Cr 0.6% -2.4% 30.8% Stock Analytics


VAISHALI PHARMA Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
VAISHALI PHARMA

-4.4%

-0.5%

13.8%

SENSEX

1.7%

1.6%

20.6%


You may also like the below Video Courses